Metheor Therapeutics Corp — Form D
Metheor Therapeutics Corp of SHORELINE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-30. The offering totals $1.5M, of which $185K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-08-30
- Form: D
- Accession: 0001528276-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $185K
- Remaining: $1.3M
- Investors: 7
- Date of first sale: 2011-08-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-165113
Issuer
- Name: Metheor Therapeutics Corp
- CIK: 0001528276
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2010
- Address: 17736 15TH AVE. NW, SHORELINE, WA, 98177
- Phone: (206) 546-3466
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Andrew Z Sledziewski | Director | Shoreline, WA |
| Andrew Z Sledziewski | Executive Officer | Shoreline, WA |
| R. Gary Schweikhardt | Director | Shoreline, WA |
| Robert Z Day | Director | Shoreline, WA |
| Theo Z DeVos | Executive Officer | Shoreline, WA |
| Gary Z Schweikhardt | Director | Shoreline, WA |
| Bruce LA Carter | Director | Seattle, WA |
Other filings by this issuer (2)
More